In releasing a finalized version of its guidance on using computational modeling and simulation (CM&S) in medical device applications submitted to the agency, the FDA expanded its explanation of the scope of the guidance. The agency also suggested an approach for getting its feedback on submitting information about models based on artificial intelligence and machine learni... Read More